Prediction: Here's What $10,000 Invested in AbbVie Stock With Dividends Reinvested Could Be Worth in a Decade

Key Points AbbVie has increased its dividend for 53 consecutive years. It has a strong pipeline and is willing to spend heavily on R&D. The company has delivered an average annual return of 20.15% over the past decade. 10 stocks we like better than AbbVie › If you were fortunate enough to invest $10,000 in AbbVie (NYSE: ABBV) stock a decade ago and reinvested its dividends, you would be sitting on $61,425.56 right now, with an average annual return of 19.91%. The pharmaceutical company, through those returns, richly rewarded the investors who bought its shares despite concerns about the patent cliff that awaited what was then the world's most lucrative drug, Humira. Missed Nvidia in 2009? This Rare Signal Is Flashing Again.